Back
Viatris, Inc. 10K Form
Sell
35
VTRS
Viatris, Inc.
Last Price:
$10.7700
Seasonality Move:
5.57%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2021-05-10 | 10Q | VTRS/Viatris, Inc. Quarterly |
| 2021-03-01 | 10K | VTRS/Viatris, Inc. Annual |
| 2020-11-10 | 10Q | VTRS/Viatris, Inc. Quarterly |
| 2020-08-12 | 10Q | VTRS/Viatris, Inc. Quarterly |
| 2020-05-12 | 10Q | VTRS/Viatris, Inc. Quarterly |
| 2020-05-07 | 10K | VTRS/Viatris, Inc. Annual |
Receive VTRS News And Ratings
See the #1 stock for the next 7 days that we like better than VTRS
VTRS Financial Statistics
Sales & Book Value
| Annual Sales: | $14.7B |
|---|---|
| Cash Flow: | $645.2M |
| Price / Cash Flow: | 7.93 |
| Annual Sales: | $13.13 |
| Price / Book: | 0.82 |
Profitability
| EPS (TTM): | -3.09790 |
|---|---|
| Net Income (TTM): | $-3.7B |
| Gross Margin: | $6.2B |
| Return on Equity: | -21.75% |
| Return on Assets: | -9.18% |
Viatris, Inc. Earnings Forecast
Key Viatris, Inc. Financial Ratios
-
The Gross Profit Margin over the past 45 years for VTRS is 42.32%.
-
The Selling, General & Administrative Expenses for VTRS have been equal to 30.09% of Gross Profit Margin.
-
The Research & Development expenses have been 5.46% of Revenue.
-
The Net Earning history of VTRS is -4.31% of Total Revenues.
-
Per Share Earnings over the last 45 years have been positive in 20 years.
Viatris, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | VTRS |
| CUSIP: | 92556V |
| Website: | viatris.com |
Debt
| Debt-to-Equity Ratio: | 0.97 |
|---|---|
| Current Ratio: | 1.26 |
| Quick Ratio: | 0.55 |
Price-to-Earnings
| Trailing P/E Ratio: | 224.8 |
|---|---|
| Forward P/E Ratio: | 4.4 |
VTRS Technical Analysis vs Fundamental Analysis
Sell
35
Viatris, Inc. (VTRS)
is a Sell
Is Viatris, Inc. a Buy or a Sell?
-
Viatris, Inc. stock is rated a SellThe current Viatris, Inc. [VTRS] share price is $10.8400. The Score for VTRS is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.